ACS
IBDQ

Archford Capital Strategies’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Archford Capital Strategies’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-88,983
Closed -$2.24M – 345
2025
Q3 		$2.24M Buy
88,983
+2,674
+3% +$67.2K 0.27% 87
2025
Q2 		$2.17M Sell
86,309
-4,170
-5% -$105K 0.28% 85
2025
Q1 		$2.28M Sell
90,479
-483
-0.5% -$12.1K 0.33% 84
2024
Q4 		$2.28M Sell
90,962
-2,290
-2% -$57.4K 0.34% 73
2024
Q3 		$2.34M Sell
93,252
-1,103
-1% -$27.5K 0.35% 70
2024
Q2 		$2.35M Buy
94,355
+3,643
+4% +$90.2K 0.38% 67
2024
Q1 		$2.25M Sell
90,712
-2,750
-3% -$68.1K 0.38% 69
2023
Q4 		$2.31M Buy
93,462
+764
+0.8% +$18.7K 0.42% 62
2023
Q3 		$2.26M Buy
92,698
+5,203
+6% +$127K 0.45% 57
2023
Q2 		$2.14M Buy
87,495
+13,319
+18% +$326K 0.41% 61
2023
Q1 		$1.82M Buy
74,176
+10,637
+17% +$260K 0.38% 63
2022
Q4 		$1.55M Sell
63,539
-18,194
-22% -$441K 0.36% 72
2022
Q3 		$1.97M Sell
81,733
-789
-1% -$19.5K 0.51% 46
2022
Q2 		$2.04M Buy
82,522
+1,065
+1% +$26.5K 0.51% 46
2022
Q1 		$2.05M Buy
81,457
+7,855
+11% +$203K 0.46% 51
2021
Q4 		$1.95M Buy
73,602
+227
+0.3% +$6.03K 0.44% 51
2021
Q3 		$1.97M Buy
73,375
+5,207
+8% +$140K 0.46% 46
2021
Q2 		$1.84M Buy
68,168
+3,700
+6% +$99.8K 0.46% 50
2021
Q1 		$1.74M Buy
64,468
+4,820
+8% +$131K 0.46% 48
2020
Q4 		$1.62M Sell
59,648
-442
-0.7% -$12K 0.37% 79
2020
Q3 		$1.63M Buy
60,090
+6,535
+12% +$177K 0.44% 66
2020
Q2 		$1.45M Buy
53,555
+16,244
+44% +$426K 0.43% 65
2020
Q1 		$932K Buy
37,311
+5,158
+16% +$133K 0.36% 82
2019
Q4 		$834K Buy
32,153
+4,447
+16% +$115K 0.29% 108
2019
Q3 		$717K Buy
27,706
+1,774
+7% +$45.6K 0.27% 121
2019
Q2 		$664K Buy
25,932
+4,161
+19% +$104K 0.24% 118
2019
Q1 		$541K Buy
21,771
+7,691
+55% +$187K 0.2% 145
2018
Q4 		$332K Buy
14,080
+2,472
+21% +$58.4K 0.13% 177
2018
Q3 		$278K Buy
11,608
+2,529
+28% +$60.7K 0.1% 194
2018
Q2 		$217K Buy
9,079
+3,674
+68% +$87.9K 0.08% 200
2018
Q1 		$135K Buy
+5,405
New +$132K 0.06% 145
2017
Q2 		– Sell
-599
Closed -$15K – 379
2017
Q1 		$15K Buy
+599
New +$14.7K 0.01% 395

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Archford Capital Strategies's IBDQ Position: Q4 2025 in Review

Archford Capital Strategies sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 88,983 shares — an estimated $2.24M sold.

Archford Capital Strategies first reported a position in IBDQ in Q1 2017 and held it in 32 quarters. The position peaked at $2.35M in Q2 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Archford Capital Strategies reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Archford Capital Strategies sold 88,983 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $2.24M.
  • Archford Capital Strategies first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2017 and held it in 32 quarters.
  • Archford Capital Strategies's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $2.35M in Q2 2024.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Archford Capital Strategies's 13F filing for Q4 2025, filed 15 Jan 2026.